DR. DANIEL NAVOT, MD
Ambulatory Health at Creston Ave, Tenafly, NJ

License number
New Jersey 25MA05844500
Category
Medical Practice
Type
Reproductive Endocrinology
License number
New Jersey 25MA05844500
Category
Ambulatory Health
Type
Ambulatory Fertility Facility
Address
Address
30 Creston Ave, Tenafly, NJ 07670
Phone
(201) 871-9106
(201) 666-2262 (Fax)

Professional information

Daniel Navot Photo 1

Fertility Prediction By Use Of Clomiphene Challenge Test

US Patent:
5091170, Feb 25, 1992
Filed:
Apr 6, 1989
Appl. No.:
7/334780
Inventors:
Daniel Navot - Tenafly NJ
International Classification:
A61K 4900
US Classification:
424 9
Abstract:
The fertility of females, especially human females can be predicted by use of a clomiphene challenge test. The test is based upon comparison of follicle stimulating hormone and/or luteinizing hormone levels in urine or blood samples at two points in the menstrual cycle. The first test is performed on days 2-3 of the cycle. Clomiphene, and most preferably clomiphene in the form of clomiphene citrate, in a dosage of about 100 mg/day, is then administered, preferably on days 5-9. The second test is conducted on days 9-10. The test results are most conveniently compared by colorimetric methods involving monoclonal antibody reactions with follicle stimulating hormone and/or luteininizing hormone.